Zoledronic acid in the management of mesothelioma - a feasibility study (Zol-A Trial): study protocol for a randomised controlled trial
DiscussionThe qualitative and quantitative data gathered in this feasibility trial will hopefully pave the way to designing a robust full phase III trial to investigate the potential synergistic effect of ZA and current standard treatment for MPM, cisplatin-pemetrexed combination chemotherapy.Trial registrationISRCTN Registry,ISRCTN45536692. Registered on 9 August 2016. EudraCT no. 2015 –004433-26.
Source: Trials - Category: Research Source Type: clinical trials
More News: Alimta | Asbestosis | Cancer | Cancer & Oncology | Chemotherapy | Colon Cancer | Colorectal Cancer | Mesothelioma | Reclast | Research | Study | Zometa